Razi Ingber
Fortune : 5 M $ au 30/09/2026
Fortune : 5 M $ au 30/09/2026
Razi Ingber currently works at RedHill Biopharma Ltd., as Chief Financial Officer from 2023.
Mr. Ingber also formerly worked at PricewaterhouseCoopers (Israel), as Audit Manager.
Mr. Ingber received his undergraduate degree and graduate degree from Tel-Aviv University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 109 680 000 ( 0,21% ) | 5 M $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| REDHILL BIOPHARMA LTD. | Directeur Financier/CFO | 01/05/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Comptroller/Controller/Auditor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
RedHill Biopharma Ltd.
RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national